← Back to Home
❀
Skin Diseases
Disease / Phenomenon
Disorders of the skin barrier and its immune environment, ranging from inflammatory flare-ups to impaired repair and pigmentation changes.
Biological Processes of Skin Diseases
Explore the key biological processes that drive skin diseases, from cellular mechanisms through tissue-level responses.
✣
Angiogenesis
1 pathway(s)
▸
Angiogenesis
1 pathway(s)
▣
VEGF Signaling
Target: VEGF
▸
VEGF Signaling
Target: VEGF
✣
Melanogenesis
2 pathway(s)
▸
Melanogenesis
2 pathway(s)
▣
α-MSH/MC1R Signaling
Target: Tyrosinase
▸
α-MSH/MC1R Signaling
Target: Tyrosinase
▣
ERK/MITF Signaling
Target: ERK
▸
ERK/MITF Signaling
Target: ERK
✣
Tissue Remodelling
4 pathway(s)
▸
Tissue Remodelling
4 pathway(s)
▣
ROS/AP-1 Signaling
Target: ROS
▸
ROS/AP-1 Signaling
Target: ROS
▣
TGF-β Signaling
Target: TGF-β
▸
TGF-β Signaling
Target: TGF-β
▣
MAPK Signaling
Target: ROS
▸
MAPK Signaling
Target: ROS
▣
Nrf2/ARE Signaling
Target: Nrf2
▸
Nrf2/ARE Signaling
Target: Nrf2
✣
Inflammation
11 pathway(s)
▸
Inflammation
11 pathway(s)
▣
IL-6/JAK/STAT Signaling
Target: IL-6
▸
IL-6/JAK/STAT Signaling
Target: IL-6
▣
IL-17A Signaling
Target: PI3K
▸
IL-17A Signaling
Target: PI3K
▣
Propionibacterium acnes/TLR-2 Signaling
Target: NF-κB
▸
Propionibacterium acnes/TLR-2 Signaling
Target: NF-κB
▣
TNFR/NF-κB Signaling
Target: NF-κB
▸
TNFR/NF-κB Signaling
Target: NF-κB
▣
PLCγ Signaling
Target: PLCγ
▸
PLCγ Signaling
Target: PLCγ
Histamine
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
▣
p38 Signaling
Target: p38
▸
p38 Signaling
Target: p38
IL-4 & IL-13
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
▣
LPS/TLR4 Signaling
Target: NF-κB
▸
LPS/TLR4 Signaling
Target: NF-κB
TNFα
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
IL-8
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
▣
TPA-induced COX-2 Signaling
Target: NF-κB
▸
TPA-induced COX-2 Signaling
Target: NF-κB
COX-2
♧ Ingredient: Black Cumin
⌬ Compound: Thymoquinone
▣
NLRP3 Signaling
Target: NLRP3
▸
NLRP3 Signaling
Target: NLRP3
IL-1β
♧ Ingredient: Black Cumin
⌬ Compound: Thymoquinone
IL-18
♧ Ingredient: Black Cumin
⌬ Compound: Thymoquinone
▣
TH1/TH2/TH17 Signaling
Target: Staphylococcus aureus membrane vesicles (MVs)
▸
TH1/TH2/TH17 Signaling
Target: Staphylococcus aureus membrane vesicles (MVs)
IFN-γ
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
IL-13
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
IL-31 and IL-17A
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
▣
Dinitrofluorobenzene-induced Inflammatory Signaling
Target: TSLP
▸
Dinitrofluorobenzene-induced Inflammatory Signaling
Target: TSLP
TSLP
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
IL-4
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
IL-6
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
✣
Itching
1 pathway(s)
▸
Itching
1 pathway(s)
✣
Skin Hydration
1 pathway(s)
▸
Skin Hydration
1 pathway(s)
▣
HA Signaling
Target: Hyaluronic acid synthase (HAS)
▸
HA Signaling
Target: Hyaluronic acid synthase (HAS)
✣
Skin Barrier Integrity
1 pathway(s)
▸
Skin Barrier Integrity
1 pathway(s)
▣
Cornified Envelope Synthesis Pathway
Target: Keratin 16
▸
Cornified Envelope Synthesis Pathway
Target: Keratin 16
Ceramide-Lipid Conjugate
♧ Ingredient: Dulse Flakes Kelp
⌬ Compound: β-Carotene
✣
Oxidative Stress
1 pathway(s)
▸
Oxidative Stress
1 pathway(s)
▣
Oxidative Stress Pathway
Target: Superoxide
▸
Oxidative Stress Pathway
Target: Superoxide
Superoxide
♧ Ingredient: Dulse Flakes Kelp
⌬ Compound: β-Carotene
Compounds affecting Skin Diseases
Browse active compounds and their direct impact on skin diseases biological processes, pathways, and biomarkers.
⌬
From Eucalyptus
▸
From Eucalyptus
✣
Inflammation
PLCγ Signaling
▸
Inflammation
PLCγ Signaling
Histamine
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
✣
Inflammation
p38 Signaling
▸
Inflammation
p38 Signaling
IL-4 & IL-13
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
✣
Inflammation
LPS/TLR4 Signaling
▸
Inflammation
LPS/TLR4 Signaling
TNFα
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
IL-8
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
⌬
From Neem
▸
From Neem
✣
Angiogenesis
VEGF Signaling
▸
Angiogenesis
VEGF Signaling
⌬
▸
⌬
▸
✣
Melanogenesis
ERK/MITF Signaling
▸
Melanogenesis
ERK/MITF Signaling
⌬
▸
⌬
▸
⌬
From Lavender
▸
From Lavender
✣
Inflammation
IL-6/JAK/STAT Signaling
▸
Inflammation
IL-6/JAK/STAT Signaling
⌬
▸
✣
Tissue Remodelling
Nrf2/ARE Signaling
▸
Tissue Remodelling
Nrf2/ARE Signaling
✣
Inflammation
Propionibacterium acnes/TLR-2 Signaling
▸
Inflammation
Propionibacterium acnes/TLR-2 Signaling
✣
Skin Hydration
HA Signaling
▸
Skin Hydration
HA Signaling
⌬
▸
⌬
▸
✣
Tissue Remodelling
MAPK Signaling
▸
Tissue Remodelling
MAPK Signaling
✣
Inflammation
TH1/TH2/TH17 Signaling
▸
Inflammation
TH1/TH2/TH17 Signaling
IFN-γ
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
IL-13
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
IL-31 and IL-17A
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
⌬
From Black Cumin
▸
From Black Cumin
✣
Inflammation
TPA-induced COX-2 Signaling
▸
Inflammation
TPA-induced COX-2 Signaling
COX-2
♧ Ingredient: Black Cumin
⌬ Compound: Thymoquinone
✣
Inflammation
NLRP3 Signaling
▸
Inflammation
NLRP3 Signaling
IL-1β
♧ Ingredient: Black Cumin
⌬ Compound: Thymoquinone
IL-18
♧ Ingredient: Black Cumin
⌬ Compound: Thymoquinone
⌬
▸
✣
Skin Barrier Integrity
Cornified Envelope Synthesis Pathway
▸
Skin Barrier Integrity
Cornified Envelope Synthesis Pathway
Ceramide-Lipid Conjugate
♧ Ingredient: Dulse Flakes Kelp
⌬ Compound: β-Carotene
✣
Oxidative Stress
Oxidative Stress Pathway
▸
Oxidative Stress
Oxidative Stress Pathway
Superoxide
♧ Ingredient: Dulse Flakes Kelp
⌬ Compound: β-Carotene
⌬
From Black Cumin
▸
From Black Cumin
✣
Inflammation
Dinitrofluorobenzene-induced Inflammatory Signaling
▸
Inflammation
Dinitrofluorobenzene-induced Inflammatory Signaling
TSLP
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
IL-4
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
IL-6
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
Ingredients affecting Skin Diseases
Explore therapeutic ingredients and their constituent compounds that modulate skin diseases biology.
♧
3 active compound(s)
▸
3 active compound(s)
⌬
Inflammation → TPA-induced COX-2 Signaling
▸
Inflammation → TPA-induced COX-2 Signaling
COX-2
♧ Ingredient: Black Cumin
⌬ Compound: Thymoquinone
⌬
Inflammation → TH1/TH2/TH17 Signaling
▸
Inflammation → TH1/TH2/TH17 Signaling
IFN-γ
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
IL-13
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
IL-31 and IL-17A
♧ Ingredient: Black Cumin
⌬ Compound: Thymol
⌬
Inflammation → Dinitrofluorobenzene-induced Inflammatory Signaling
▸
Inflammation → Dinitrofluorobenzene-induced Inflammatory Signaling
TSLP
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
IL-4
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
IL-6
♧ Ingredient: Black Cumin
⌬ Compound: β-Sitosterol
♧
0 active compound(s)
▸
0 active compound(s)
♧
1 active compound(s)
▸
1 active compound(s)
⌬
Tissue Remodelling → Nrf2/ARE Signaling
▸
Tissue Remodelling → Nrf2/ARE Signaling
♧
1 active compound(s)
▸
1 active compound(s)
⌬
Skin Barrier Integrity → Cornified Envelope Synthesis Pathway
▸
Skin Barrier Integrity → Cornified Envelope Synthesis Pathway
Ceramide-Lipid Conjugate
♧ Ingredient: Dulse Flakes Kelp
⌬ Compound: β-Carotene
♧
1 active compound(s)
▸
1 active compound(s)
⌬
Inflammation → PLCγ Signaling
▸
Inflammation → PLCγ Signaling
Histamine
♧ Ingredient: Eucalyptus
⌬ Compound: 1,8‑Cineole
♧
0 active compound(s)
▸
0 active compound(s)
♧
3 active compound(s)
▸
3 active compound(s)
⌬
Tissue Remodelling → TGF-β Signaling
▸
Tissue Remodelling → TGF-β Signaling
⌬
Inflammation → IL-6/JAK/STAT Signaling
▸
Inflammation → IL-6/JAK/STAT Signaling
♧
3 active compound(s)
▸
3 active compound(s)
⌬
Angiogenesis → VEGF Signaling
▸
Angiogenesis → VEGF Signaling
⌬
Melanogenesis → α-MSH/MC1R Signaling
▸
Melanogenesis → α-MSH/MC1R Signaling
♧
1 active compound(s)
▸
1 active compound(s)
♧
1 active compound(s)
▸
1 active compound(s)
⌬
Melanogenesis → ERK/MITF Signaling
▸
Melanogenesis → ERK/MITF Signaling